Navigation Links
Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009
Date:3/4/2011

ble healthcare providers on the Transition List will be sent notice of the settlement.  The settlement applies to approximately 20,000 SS1 Devices owned by approximately 6,600 customers.   Based on the number of Eligible SS1 Devices and settlement options made available to each, C&T estimates that the settlement provides approximately $20 million of benefits to the class.  

The benefits that class members can elect to receive differs depending on whether they are members of Sub-Class A, Sub-Class B, or Sub-Class C:  Sub-ClassDescription

Settlement ConsiderationA

Class Members that (a) purchased or elect to purchase SYSTEM 1E™  ("SS1E") Device from STERIS on or before December 31, 2012, and (b) either (i) still have the Eligible SS1 Device(s) or (ii) returned the Eligible SS1 Device(s) to STERIS in the Rebate Program.  The SS1E is STERIS' next generation liquid chemical sterilant processing system.

Will receive SS1E Credits in the amount of $1,000.00 per Eligible SS1 Device, which can be applied towards the purchase of any SS1E Accessories, Parts Or Consumables; SS1E credits can be combined, and must be claimed by December 31, 2012.Class Members that (a) do not elect to purchase an SS1E Device and (b) either (i) still have the Eligible SS1 Device(s) or (ii) returned the Eligible SS1 Device(s) to STERIS in the Rebate Program.

Will, for each Eligible SS1 Device, have the option to receive either (a) $500 in STERIS Product Credits, or (b) $300.00 in cash.  STERIS Product Credits may be redeemed for any STERIS product(s) other than an SS1E Device, service, or service contracts.  STERIS Product Credits can be combined and must be claimed by December 31, 2012. C

Class Members that, for any reason other than because the Eligible SS1 Device was returned to STERIS in the Rebate Program, no longer have the Eligible SS1 Device.

Will be entitled to receive a $200.00 cash payment
'/>"/>

SOURCE Chimicles & Tikellis LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. German High Court Rules in Favor of AmniSure® as New European Guidelines Published
2. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
3. Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.
4. Final Superior Court Ruling on Trade Secret Lawsuit Favors Volcano Corporation and Its Axsun Subsidiary
5. Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
6. Massachusetts Court Rules in Favor of Volcano and Against St. Jude Medical Subsidiary in Trade Secrets Case
7. Sensipar® Patents Upheld By District Court
8. U.S. District Court Rules from Bench in Lillys Favor, Confirms Validity of Alimta Patent
9. Occlutech Wins Dutch Appeal Court Ruling Against AGA Medical
10. Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case
11. Statement of Ben Anderson, Esq., Regarding Denial of Wyeths En Banc Petition to Sixth Circuit Court of Appeals in Major Drug Regulation Pre-emption Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 2015 VWR (NASDAQ: VWR ), ... announces the redesign of its global website, www.vwr.com , ... visiting the new site, guests will enjoy enhanced content on ... images.  Each country site now includes: , ... menu; and , the ability to search by discipline/industry. ...
(Date:8/3/2015)... 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) ... Quarter 2015 Investor Conference Call and webcast at 4:30 p.m., ... call will cover an update on Merrimack,s progress as ... A press release detailing the information to be discussed ... Monday, August 10. Investors and the general public are ...
(Date:8/3/2015)... and FLORHAM PARK, N.J. ... that once-daily naldemedine met its primary and secondary endpoints ... treatment of opioid-induced constipation (OIC) in adult patients with ... acting mu-opioid receptor antagonist (PAMORA). This is the third ... and key secondary endpoints. Study results showed ...
Breaking Medicine Technology:VWR's New Website Redesign Provides Improved Functionality for Customers 2Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4
... Orbitz Worldwide, Inc. (NYSE: OWW ) will host a conference call to ... on Wednesday, May 5, 2010 at 10:00 a.m. EDT ( 9:00 ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20070813/AQM125LOGO ) , ... A live webcast of the call can be accessed through the Orbitz Worldwide ...
... April 26 Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced ... will present at Deutsche Bank,s 35th Annual Health Care Conference on Monday, ... InterContinental Boston Hotel in Boston, MA. , ... A live webcast of the presentation may be accessed from the ...
Cached Medicine Technology:Orbitz Worldwide, Inc. to Host First Quarter 2010 Earnings Call on May 5 2Orbitz Worldwide, Inc. to Host First Quarter 2010 Earnings Call on May 5 3
(Date:8/4/2015)... ... August 04, 2015 , ... More than 700 years of marital bliss ... on Friday, July 24th. Chaplains Shawn Kafader and Richard Oas lead the non-denominational ... the ceremony was a reception, with music by the Moonlight Serenade Orchestra and a ...
(Date:8/4/2015)... ... 2015 , ... Centurion Service Group, the world's largest medical equipment auction house, ... , The live auction will take place on Thursday, August 6 beginning ... at 5025 North Hiatus Road Sunrise, FL 33351. Anyone can participate in the auction ...
(Date:8/4/2015)... ... August 04, 2015 , ... Dr. Gary Richter, ... America’s Favorite Veterinarian. The contest is put on by the American Veterinary Medical ... nominees. Nominees were evaluated on community involvement, ethical behavior, passion for profession, and ...
(Date:8/4/2015)... ... August 04, 2015 , ... The goal of looking ... the desire for invasive surgery to achieve this ideal is not. But minimally invasive ... crave without the high cost or lengthy recovery time, according to Valerie Goldburt, ...
(Date:8/4/2015)... ... August 04, 2015 , ... The Law Offices of Ben C. ... claims dealing with Inferior Vena Cava Filters (“IVC Filters”). , As lead IVC filter ... Cook IVC Filter clients under In re Cook Medical, Inc., IVC Filters Marketing, Sales ...
Breaking Medicine News(10 mins):Health News:Couples Renew Vows at Friendship Village of Schaumburg 2Health News:Medical Equipment Auction to Take Place in Fort Lauderdale 2Health News:Dr. Gary Richter, Oakland Holistic Veterinarian, Among 20 Finalists for America’s Favorite Veterinarian 2Health News:Dr. Gary Richter, Oakland Holistic Veterinarian, Among 20 Finalists for America’s Favorite Veterinarian 3Health News:Considering fillers, tighteners or laser resurfacing? 2Health News:Considering fillers, tighteners or laser resurfacing? 3Health News:Considering fillers, tighteners or laser resurfacing? 4Health News:Law Offices of Ben C. Martin in Dallas Files New IVC Filter Complications Lawsuits and Pursues Settlements 2Health News:Law Offices of Ben C. Martin in Dallas Files New IVC Filter Complications Lawsuits and Pursues Settlements 3
... , , , , ... The Ohio Nurses Association/Youngstown General Duty Nurses Association (ONA/YGDNA) ratified a ... process has resulted in the Registered Nurses of Northside Medical Center ... It is now up to the Forum Health management and ...
... , ANNAPOLIS, Md., July 27 ... company developing medical countermeasures against biological and chemical threats, today ... of 2-year, 10% unsecured senior convertible notes ("Notes") and common ... $19.3 million. , , In connection with ...
... BOZEN, Italy, July 27 Health Robotics today ... i.v.SOFT in order to market,implement, and support its I.V. ... infusion centers in North America. One of,its software modules ... at the University of Colorado Hospital [Denver], ...
... , , FRANKLIN LAKES, N.J., ... living in the country,s fifth largest city are now faced with ... Many commonly used therapy classes including drugs to treat diabetes, high ... in adults 20 and older. , , ...
... , , , Trinitas ... has new oral chemotherapy program in place ... availability of oral chemotherapy for treating a variety of cancers--along with projections ... drugs will be in oral form by 2013--raise questions for both clinicians ...
... , COLD SPRING HARBOR, N.Y., July 27 ... hand-held, non-contact vein illumination device, today announced that its quality ... Certification. This certifies to customers around the globe AccuVein,s commitment ... development, production, installation and delivery procedures. , ...
Cached Medicine News:Health News:PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants 2Health News:PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants 3Health News:PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants 4Health News:Health Robotics Announces American Joint Venture With i.v.SOFT 2Health News:Health Robotics Announces American Joint Venture With i.v.SOFT 3Health News:Chronic and Complex Diseases on the Rise in Philadelphia: Adults Using More Medications to Treat Chronic Conditions 2Health News:Chronic and Complex Diseases on the Rise in Philadelphia: Adults Using More Medications to Treat Chronic Conditions 3Health News:Chronic and Complex Diseases on the Rise in Philadelphia: Adults Using More Medications to Treat Chronic Conditions 4Health News:Oral Chemotherapy Offers Patients a More Convenient, Less Invasive Treatment Option 2Health News:Oral Chemotherapy Offers Patients a More Convenient, Less Invasive Treatment Option 3Health News:AccuVein Achieves Quality System Milestone 2
Near PT test card/Tumbling E, tumbling hands 5 1/2" X 8"....
... PowerLab 2/25 is an economically priced ... teaching and research use in the ... pharmacology, neurophysiology, biology, zoology, biochemistry and ... all ADInstruments signal conditioners and transducers. ...
... Biomuse, a powerful, 8 channel "biocontroller" that ... bioelectric signal, and then outputs code to ... is intended for use as a development ... has licensed the Biomuse to selected research ...
They employ Lea Symbols. Contrast levels are the same at 25%, 10%, 5%, 2.5% and 1.25%. Each offers a different set of Lea Symbols to guard against memorization. Also uses recording forms (P/N 215400)...
Medicine Products: